[HTML][HTML] Emerging roles of ceramide in cardiovascular diseases

H Shu, Y Peng, W Hang, N Li, N Zhou… - Aging and …, 2022 - ncbi.nlm.nih.gov
Ceramide is a core molecule of sphingolipid metabolism that causes selective insulin
resistance and dyslipidemia. Research on its involvement in cardiovascular diseases has …

Ceramide metabolism in cardiovascular disease: a network with high therapeutic potential

A Zietzer, P Düsing, L Reese, G Nickenig… - … , and Vascular Biology, 2022 - Am Heart Assoc
Growing evidence suggests that ceramides play an important role in the development of
atherosclerotic and valvular heart disease. Ceramides are biologically active sphingolipids …

Ceramides as mediators of oxidative stress and inflammation in cardiometabolic disease

M Gaggini, R Ndreu, E Michelucci… - International Journal of …, 2022 - mdpi.com
Ceramides, composed of a sphingosine and a fatty acid, are bioactive lipid molecules
involved in many key cellular pathways (eg, apoptosis, oxidative stress and inflammation) …

[HTML][HTML] Ceramides and other sphingolipids as drivers of cardiovascular disease

RH Choi, SM Tatum, JD Symons… - Nature Reviews …, 2021 - nature.com
Increases in calorie consumption and sedentary lifestyles are fuelling a global pandemic of
cardiometabolic diseases, including coronary artery disease, diabetes mellitus …

Ceramides improve atherosclerotic cardiovascular disease risk assessment beyond standard risk factors

JW Meeusen, LJ Donato, SL Kopecky, VC Vasile… - Clinica Chimica …, 2020 - Elsevier
Ceramides are bioactive lipids that act as secondary messengers for both intra-and inter-
cellular signaling. Elevated plasma concentrations of ceramides are associated with multiple …

[HTML][HTML] Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies

KA McGurk, BD Keavney, A Nicolaou - Atherosclerosis, 2021 - Elsevier
There is a need for new biomarkers of atherosclerotic cardiovascular disease (ACVD), the
main cause of death globally. Ceramides, a class of potent bioactive lipid mediators, have …

Ceramides are fuel gauges on the drive to cardiometabolic disease

JL Wilkerson, SM Tatum, WL Holland… - Physiological …, 2024 - journals.physiology.org
Ceramides are signals of fatty acid excess that accumulate when a cell's energetic needs
have been met and its nutrient storage has reached capacity. As these sphingolipids accrue …

Plasma ceramides pathophysiology, measurements, challenges, and opportunities

M Gaggini, A Pingitore, C Vassalle - Metabolites, 2021 - mdpi.com
Ceramides are a family of lipid molecules, composed of sphingosine and a fatty acid, and
transported by lipoproteins (primarily by low-density lipoproteins) in the bloodstream. They …

Ceramides as novel disease biomarkers

J Kurz, MJ Parnham, G Geisslinger… - Trends in molecular …, 2019 - cell.com
Ceramides are sphingolipids and integral components of the eukaryotic cell membrane.
Apart from providing structural integrity, ceramides have also been shown to act as second …

Ceramides in metabolism: key lipotoxic players

B Chaurasia, SA Summers - Annual review of physiology, 2021 - annualreviews.org
The global prevalence of metabolic diseases such as type 2 diabetes mellitus,
steatohepatitis, myocardial infarction, and stroke has increased dramatically over the past …